维普期刊资源整合服务平台（V6.5）

82篇 您的检索式：作者名="FINEMAN MS"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Effect on glycemic control of synthetic Exendin-4 (AC2993) additive to existing metforrnin and/or sulfonylurea treatment in patients with type 2 diabetes显示文摘	Fineman MS Bicsak TA Shen LZ	2003	Diabetes Care2003，26，8：	1
2	Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated patients with type 2 diabetes显示文摘	Ratner R Want LL Fineman MS	2002	Diabetes Technol Ther2002，4，1：	1
3	Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus 显示文摘	Koherman OG Kim DD Shen L Ruggles JA Nielsen LL Fineman MS	2005	Am J Health Syst Pharm2005，62，2：	1
4	Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes:a 1-year randomized controlled trial显示文摘	Hollander PA Levy P Fineman MS	2003	Diabates Care2003，26，3：	1
5	Effectiveness of progressive does-escalation of exenatide ( exendin-4 ) in reducing doselimiting side effects in patients with type 2 diabetes 显示文摘	Fineman MS Shen LZ Taylor K	2004	J Diabetes Metab Res Rev2004，20，5：	1
6	Adjunctive therapy with pramlintide lowers HbAlc without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets 显示文摘	Ratner R Whitehouse F Fineman MS	2005	Exp Clin Endocrinol Diabetes2005，113，4：	1
7	Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial 显示文摘	Hollander PA Levy P Fineman MS	2003	Diabetes Care2003，26，3：	1
8	Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery显示文摘	Fineman MS Brown GC	2006	Ophthalmology2006，113，1：	1
9	Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment显示文摘	Shah CP Ho AC Regillo CD Fineman MS Vander JF Brown GC		0，，05：	1
10	Synthetic ex- endin- 4 ( AC2993 ) significantly reducespostprandial and fasting plasma glucose in subjects with type 2 diabetes 显示文摘	Koherman OG Buse JB Fineman MS	2003	Clin Endocrinol Metab2003，88，7：	1
11	Bilateral choroidal effusions and angle-closure glaucoma associated with human immunodeficiency virus infection显示文摘	Fineman MS Emerick G Dudley D Katz LJ Maguire JI	1997	Retina1997，17，：	1
12	Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes显示文摘	Kolterman OG Buse JB Fineman MS	2003	J Clin Endocrinol Metab2003，88，7：	1
13	Incidence of intraocular pressure spike and other adverse events after vitreoretinal surgery显示文摘	Anderson N G Fineman MS Brown GC	2006	Ophthalmology2006，113，：	1
14	The human amylin anaiogue,pramlintide,corrects postprandial hyperglucagonemia in patients with type 1 diabetes显示文摘	Fineman MS Koda JE Shen LZ	2002	Metabosim2002，51，5：	1
15	Synthetic Exendin-4 (AC2993) Signify eantly reduces post-prandial and fasting plasma glucose insubjects with type 2 diabetes显示文摘	Kolterman OG Buse JB Fineman MS	2003	Clin Endocrinol Metab2003，88，7：	1
16	Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes 显示文摘	Kolterman OG Buse JB Fineman MS	2003	J Clin Endocrinal Metab2003，88，7：	1
17	Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes : a 1- year randomized controlled trial 显示文摘	Hollander PA Levy P Fineman MS	2003	Diabetes Care2003，26，3：	1
18	Synthetic exendin-4 (AC2993) significantly reduces postprandial and fasting plasma glu- cose in subjects with type 2 diabetes 显示文摘	Kolterman OG Buse JB Fineman MS	2003	J Clin Endocrinol Metab2003，88，7：	1
19	Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and /or sulfonylurea treatment in patients with type 2 diabetes显示文摘	Fineman MS Bicsak TA Shen LZ	2003	Diabetes Care2003，26，8：	1
20	Synthetic exendin-4(exeatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes显示文摘	Kolterman OG Buse JB Fineman MS	2003	J Clin Endocrinol Metab2003，88，7：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示